Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 22211 

Dated: April 14, 2015. 

Genevieve deAlmeida, 

Project Clearance Liaison, National Institute 

on Drug Abuse. 

[FR Doc. 2015–09089 Filed 4–20–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel, Child Health and the 

Environment Review Committee. 

Date: May 12–14, 2015. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal City Marriott at Reagan 

National Airport, 1999 Jefferson David 

Highway, Arlington, VA 22202. 

Contact Person: Linda K Bass, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research and 

Training, Nat’l Institute Environmental 

Health Sciences, P.O. Box 12233, MD EC–30, 

Research Triangle Park, NC 27709, (919) 541– 

1307. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel, Cell Differentiation Assays. 

Date: May 15, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Chapel Hill, One Europa 

Drive, Chapel Hill, NC 27517. 

Contact Person: Sally Eckert-Tilotta, Ph.D., 

Scientific Review Officer, Nat. Institute of 

Environmental Health Sciences, Office of 

Program Operations, Scientific Review 

Branch, P.O. Box 12233, Research Triangle 

Park, NC 27709, (919) 541–1446 eckertt1@

niehs.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: April 15, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–09061 Filed 4–20–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Prostate, Lung, Colorectal 

and Ovarian Cancer Screening Trial 

(PLCO) (NCI) 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI), 

National Institutes of Health (NIH), will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Written comments and/or suggestions 

from the public and affected agencies 

are invited on one or more of the 

following points: (1) Whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

To Submit Comments and for Further 

Information: To obtain a copy of the 

data collection plans and instruments, 

submit comments in writing, or request 

more information on the proposed 

project, contact: Kelly Yu, Ph.D., 

Division of Cancer Prevention, 9609 

Medical Center Drive, Room 5E230, 

Rockville, MD 20850 or call non-tollfree number 240–276–7041 or Email 

your request, including your address to: 

yuke@mail.nih.gov. Formal requests for 

additional plans and instruments must 

be requested in writing. 

Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Proposed Collection: Prostate, Lung, 

Colorectal, and Ovarian Cancer 

Screening Trial (PLCO), 0925–0407, 

Extension, National Cancer Institute 

(NCI), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: This is a request for a 

revision of the Prostate, Lung, Colorectal 

and Ovarian Cancer Screening Trial 

(PLCO). This trial was designed to 

determine if cancer screening for 

prostate, lung, colorectal, and ovarian 

cancer can reduce mortality from these 

cancers which caused an estimated 

253,320 deaths in the U.S. in 2014. The 

design is a two-armed randomized trial 

of men and women aged 55 to 74 at 

entry. OMB first approved this study in 

1993 and has approved it every 3 years 

since then. Recruitment was completed 

in 2001, baseline cancer screening was 

completed in 2006, and data collection 

continues on the current cohort of 

77,281 participants who are actively 

being followed. The additional followup will provide data that will clarify 

further the long term effects of the 

screening on cancer incidence and 

mortality for the four targeted cancers. 

Further, demographic and risk factor 

information may be used to analyze the 

differential effectiveness of cancer 

screening in high versus low risk 

individuals. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

26,320. 


tkelley on DSK3SPTVN1PROD with NOTICES